Discover

HSIC
Henry Schein, Inc.
84.52
2 x 78.21
2 x 90.66
bid
ask
+
1.00
1.20%
2 @ 04:00 PM
84.52 +0.00 (0.00%)
Ytd11.83%
1y13.48%
83.47
day range
85.47
61.95
52 week range
89.29
Open83.47Prev Close83.52Low83.47High85.47Mkt Cap9.63B
Vol995.37KAvg Vol1.42MEPS3.31P/E25.53Forward P/E14.29
Beta0.82Short Ratio5.15Inst. Own108.22%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg76.71200-d Avg74.241yr Est88.07

HSIC News

GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
prnewswire.com
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwi

MIAMI, June 30, 2026 /PRNewswire/ -- GoTu Technology, the nation's leading dental talent marketplace

This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
benzinga.com
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page a

This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
benzinga.com
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Wall Street analysts change outlook for top stocks. See upgrades, downgrades, and initiations on ana

benzinga.com
BTIG Upgrades Henry Schein to Buy, Announces $100 Price Target

BTIG analyst David Larsen upgrades Henry Schein (NASDAQ:HSIC) from Neutral to Buy and announces $

benzinga.com
Henry Schein Appoints William K. Daniel As Board Chairman, Effective Immediately

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to offi

benzinga.com
UBS Maintains Neutral on Henry Schein, Lowers Price Target to $85

UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the pri

benzinga.com
Mizuho Maintains Neutral on Henry Schein, Lowers Price Target to $82

Mizuho analyst Steven Valiquette maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers t

Transcript: Henry Schein Q1 2026 Earnings Conference Call
benzinga.com
Transcript: Henry Schein Q1 2026 Earnings Conference Call

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

benzinga.com
Henry Schein Affirms FY2026 Adj EPS Guidance of $5.23-$5.37 vs $5.32 Est; Affirms FY2026 Sales Guida

Henry Schein (NASDAQ:HSIC) affirms FY2026 Adj EPS guidance from $5.23-$5.37 to $5.23-$5.37 vs $5.32

benzinga.com
Henry Schein Q1 Adj. EPS $1.32 Beats $1.22 Estimate, Sales $3.368B Beat $3.342B Estimate

Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.32 per share which beat the analyst con

benzinga.com
Morgan Stanley Maintains Underweight on Henry Schein, Raises Price Target to $64

Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and ra

This Dick's Sporting Goods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga.com
This Dick's Sporting Goods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For

Top analysts change outlook on top names, check analyst ratings page for all changes. Keybanc initia

benzinga.com
Citigroup Initiates Coverage On Henry Schein with Buy Rating, Announces Price Target of $100

Citigroup analyst Daniel Grosslight initiates coverage on Henry Schein (NASDAQ:HSIC) with a Buy r

benzinga.com
Evercore ISI Group Maintains Outperform on Henry Schein, Lowers Price Target to $90

Evercore ISI Group analyst Elizabeth Anderson maintains Henry Schein (NASDAQ:HSIC) with a Outperf

benzinga.com
Henry Schein Chairman Stanley M. Bergman to Retire After 44 Years, Board Shrinks to 10 Members

Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office

benzinga.com
Biomerica Announces Responder Analysis Results From Ongoing Real-World Study Of inFoods IBS

Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30%

benzinga.com
Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $97

Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperfor

benzinga.com
UBS Maintains Neutral on Henry Schein, Raises Price Target to $87

UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the pri

benzinga.com
JP Morgan Maintains Overweight on Henry Schein, Raises Price Target to $92

JP Morgan analyst John Stansel maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises

These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results
benzinga.com
These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results

benzinga.com
Mizuho Maintains Neutral on Henry Schein, Raises Price Target to $88

Mizuho analyst Steven Valiquette maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises t

benzinga.com
Morgan Stanley Maintains Underweight on Henry Schein, Raises Price Target to $61

Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and ra

benzinga.com
Wells Fargo Maintains Equal-Weight on Henry Schein, Raises Price Target to $87

Wells Fargo analyst Vik Chopra maintains Henry Schein (NASDAQ:HSIC) with a Equal-Weight and raise

benzinga.com
Evercore ISI Group Maintains Outperform on Henry Schein, Raises Price Target to $100

Evercore ISI Group analyst Elizabeth Anderson maintains Henry Schein (NASDAQ:HSIC) with a Outperf

Analyst Expectations For Henry Schein's Future
benzinga.com
Analyst Expectations For Henry Schein's Future

benzinga.com
Leerink Partners Maintains Market Perform on Henry Schein, Raises Price Target to $87

Leerink Partners analyst Michael Cherny maintains Henry Schein (NASDAQ:HSIC) with a Market Perfor

Henry Schein Stock Hits 52-Week High - Here's Why
benzinga.com
Henry Schein Stock Hits 52-Week High - Here's Why

Henry Schein beats Q4 earnings and sales estimates, guides steady 2026 growth as shares climb nearly

Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday

Earnings Scheduled For February 24, 2026
benzinga.com
Earnings Scheduled For February 24, 2026

benzinga.com
Henry Schein Sees FY2026 Adj EPS $5.23-$5.37 vs $5.30 Est; Sees Sales $13.580B-$13.843B vs $13.533B

Henry Schein (NASDAQ:HSIC) is looking for FY2026 Adj EPS of $5.23-$5.37 vs $5.30 analyst estimate. s

Earnings Breakdown: Henry Schein Q4
benzinga.com
Earnings Breakdown: Henry Schein Q4

benzinga.com
Henry Schein Q4 Adj. EPS $1.34 Beats $1.30 Estimate, Sales $3.437B Beat $3.345B Estimate

Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.34 per share which beat the analyst con

Earnings Preview: Henry Schein
benzinga.com
Earnings Preview: Henry Schein

This Henry Schein Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
benzinga.com
This Henry Schein Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

benzinga.com
Baird Upgrades Henry Schein to Outperform, Raises Price Target to $100

Baird analyst Jeff Johnson upgrades Henry Schein (NASDAQ:HSIC) from Neutral to Outperform and rai

benzinga.com
Mizuho Maintains Neutral on Henry Schein, Raises Price Target to $81

Mizuho analyst Steven Valiquette maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises t

benzinga.com
Henry Schein Enters Into New Exclusive Distribution Agreement With CytoChip For Its CitoCBC System,

Partnership Expands Access to FDA-Cleared CitoCBC® System Across the U.S.Henry Schein, Inc. (NASDAQ:

benzinga.com
Henry Schein Expects To Appoint New CEO By Mid-January 2026

Henry Schein, Inc. (NASDAQ:HSIC) (the "Company"), the world's largest provider of health

Top 2 Health Care Stocks That May Keep You Up At Night In December
benzinga.com
Top 2 Health Care Stocks That May Keep You Up At Night In December

benzinga.com
Barclays Initiates Coverage On Henry Schein with Overweight Rating, Announces Price Target of $86

Barclays analyst Glen Santangelo initiates coverage on Henry Schein (NASDAQ:HSIC) with a Overweig

Peering Into Henry Schein Inc's Recent Short Interest
benzinga.com
Peering Into Henry Schein Inc's Recent Short Interest

10 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks
benzinga.com
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as invest

16 Stocks To Buy If You Want To Escape The AI Hype
benzinga.com
16 Stocks To Buy If You Want To Escape The AI Hype

Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no di

Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker
benzinga.com
Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker

On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and

benzinga.com
JP Morgan Maintains Overweight on Henry Schein, Raises Price Target to $78

JP Morgan analyst John Stansel maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises

benzinga.com
Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $79

Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperfor

benzinga.com
Morgan Stanley Maintains Underweight on Henry Schein, Raises Price Target to $58

Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and ra

benzinga.com
Wells Fargo Maintains Equal-Weight on Henry Schein, Raises Price Target to $76

Wells Fargo analyst Vik Chopra maintains Henry Schein (NASDAQ:HSIC) with a Equal-Weight and raise